Correlation Between Acumen Pharmaceuticals and Inozyme Pharma
Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and Inozyme Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and Inozyme Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acumen Pharmaceuticals and Inozyme Pharma, you can compare the effects of market volatilities on Acumen Pharmaceuticals and Inozyme Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of Inozyme Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and Inozyme Pharma.
Diversification Opportunities for Acumen Pharmaceuticals and Inozyme Pharma
0.25 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Acumen and Inozyme is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and Inozyme Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inozyme Pharma and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with Inozyme Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inozyme Pharma has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and Inozyme Pharma go up and down completely randomly.
Pair Corralation between Acumen Pharmaceuticals and Inozyme Pharma
Given the investment horizon of 90 days Acumen Pharmaceuticals is expected to generate 13.41 times less return on investment than Inozyme Pharma. But when comparing it to its historical volatility, Acumen Pharmaceuticals is 4.49 times less risky than Inozyme Pharma. It trades about 0.05 of its potential returns per unit of risk. Inozyme Pharma is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest 91.00 in Inozyme Pharma on March 29, 2025 and sell it today you would earn a total of 309.00 from holding Inozyme Pharma or generate 339.56% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Acumen Pharmaceuticals vs. Inozyme Pharma
Performance |
| Timeline |
| Acumen Pharmaceuticals |
| Inozyme Pharma |
Acumen Pharmaceuticals and Inozyme Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acumen Pharmaceuticals and Inozyme Pharma
The main advantage of trading using opposite Acumen Pharmaceuticals and Inozyme Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, Inozyme Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inozyme Pharma will offset losses from the drop in Inozyme Pharma's long position.| Acumen Pharmaceuticals vs. Terns Pharmaceuticals | Acumen Pharmaceuticals vs. X4 Pharmaceuticals | Acumen Pharmaceuticals vs. Day One Biopharmaceuticals | Acumen Pharmaceuticals vs. Hookipa Pharma |
| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |